Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

Stock Information for WW International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About WW International Inc.

Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo® Available Through LillyDirect
Weight Watchers Announces Board Committee Appointments
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Weight Watchers Announces Leadership Transition and Board Updates 
Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.